Pfizer-Allergan Merger Won’t Lead to New, Innovative Drugs
Donald Conway T’72 comments on the $160 billion Pfizer-Allergan deal that instantly turned the combined company, Pfizer Plc, into the world's largest drug maker. Conway argues that these types of mergers are going to increase the cost of health care.